Medicine is hard, but there probably isn’t anything harder to solve in medicine than the obesity epidemic. The CDC considers 42% of Americans obese. That fact didn’t scare off John’s guest this week. His name is Shantanu Gaur, the co-founder of Allurion Technologies, a leader in the development of innovative, scalable and weight loss solutions. Shantanu describes his journey from Harvard medical school to starting Allurion and how they built the Elipse Balloon, the world’s first and only procedureless gastric balloon for weight loss.
Find out more about Allurion here.
About Shantanu Gaur:
Shantanu founded Allurion Technologies with one goal: end obesity. Dr. Gaur founded Allurion while at Harvard Medical School and has overseen the company’s research and development, clinical programs, and commercial operations.
Allurion developed and commercialized the world’s first weight loss platform—including devices, digital therapeutics, and nutritional programs—to treat obesity. The company has already treated over 40,000 consumers, shed an estimated 1 million pounds, and grown revenues at 100%+ CAGR over the past 4 years. The company grew by 150% in the second half of 2020 as it experienced unprecedented demand after the COVID-19 quarantines lifted.
The Allurion Weight Loss Program features the Elipse® Balloon—the world’s first and only procedureless gastric balloon for weight loss—the Allurion® Virtual Care Suite of wearables and telehealth and AI-powered software that provide real-time insights to both patients and providers, and the Allurion “Honeymoon from Hunger” personalized nutritional and behavior change coaching program. On average, consumers lose 30 pounds in just 4 months on the Allurion Program.
Since Allurion’s inception in 2009, the company has raised over $80 million. The company is headquartered in Natick, MA with offices in Paris, Dubai, and Hong Kong. Allurion has been recognized as one of Fierce Medical Device’s Fierce 15, one of Boston’s 50onFire, and a top Emerging Technology by SAGES.
Shantanu is an inventor on over 40 patents and has authored multiple peer-reviewed publications. He has been featured on CNBC and Bloomberg and invited to speak on Allurion, obesity, and medical device innovation at numerous worldwide events.
Shantanu graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School where he was a Paul Revere Frothingham Scholar and Paul & Daisy Soros Fellow. He is originally from Bethel Park, PA and now lives in Dover, MA with his wife Neha and son Yuvraj.
Hosted By: John Shufeldt